MARC 닫기

• LDR

  04890cam a2200793Mu 4500

• 001

  000001332943

• 005

  20210114161919

• 006

  m d

• 007

  cr -n---------

• 008

  180519s2018 xx o 000 0 eng d

• 019

  ▼a  1035762560
  ▼a  1036107280
  ▼a  1036107377
  ▼a  1051399568
  ▼a  1053900183

• 020

  ▼a  9780429015939

• 020

  ▼a  0429015933

• 020

  ▼a  9780429015922

• 020

  ▼a  0429015925

• 020

  ▼z  9781138581043

• 020

  ▼z  1138581046

• 020

  ▼z  9780429506970 (ebook)

• 024

  ▼a  10.4324/9780429506970
  ▼2  doi

• 035

  ▼a  1776354
  ▼b  (N$T)

• 035

  ▼a  (OCoLC)1036764859
  ▼z  (OCoLC)1035762560
  ▼z  (OCoLC)1036107280
  ▼z  (OCoLC)1036107377
  ▼z  (OCoLC)1051399568
  ▼z  (OCoLC)1053900183

• 037

  ▼a  9780429015922
  ▼b  Ingram Content Group

• 040

  ▼a  EBLCP
  ▼b  eng
  ▼c  EBLCP
  ▼d  IDB
  ▼d  NLE
  ▼d  YDX
  ▼d  N$T
  ▼d  248023

• 050

  ▼a  RS380
  ▼b  .K36 2018eb

• 060

  ▼a  2018 F-543

• 060

  ▼a  QV 736.1

• 072

  ▼a  BUS
  ▼x  071000
  ▼2  bisacsh

• 072

  ▼a  BUS
  ▼x  072000
  ▼2  bisacsh

• 082

  ▼a  338.476151
  ▼2  23

• 100

  ▼a  Kansal, Ruchin.

• 245

  ▼a  Redefining Innovation
  ▼h  [electronic resource]:
  ▼b  Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry.

• 260

  ▼a  Milton:
  ▼b  Productivity Press,
  ▼c  2018.

• 300

  ▼a  1 online resource (229 p.).

• 336

  ▼a  text
  ▼2  rdacontent

• 337

  ▼a  computer
  ▼2  rdamedia

• 338

  ▼a  online resource
  ▼2  rdacarrier

• 500

  ▼a  Description based upon print version of record.

• 504

  ▼a  Includes bibliographical references and index.

• 505

  ▼a  Cover; Half Title; Title Page; Copyright Page; Contents; Reviews; Setting the Context; Foreword; Preface; Acknowledgments; The 80-80 Rule; Section I: Redefining Innovation; 1. Rise of a Unicorn Industry; Unintended Consequences of Disconnected Choices; The Western Biopharmaceutical Industry Takes Shape; The Golden Era; A "Unicorn Industry" Is in Place; A Perspective on Global Differences in Reimbursement of Biopharmaceuticals; Endnotes; 2. The Unicorn Industry Loses Its Wings; Limited White Spaces for Traditional Product-Focused Innovation; Therapies versus Cures

• 505

  ▼a  Outcome and Value versus Safety and EfficacyTransition from Old to New Technology; Commoditization; Consumerism; New Disruptors; Evolution of the Regulatory Framework as a Source of Disruption; An Industry Perspective; The Future?; Endnotes; 3. An Experiment in Challenging the Status Quo; Challenging the Status Quo; Innovation Is Not a Choice; Endnotes; 4. Innovation Redefined; Redefining Innovation; Drive the Core, but Know It Is a Short-Term Game; Invest in Adjacent; It Is Easier to Execute; Experiment with Breakthrough to Define New Futures; Beyond Healthcare; Endnotes

• 505

  ▼a  5. Next-Generation Unicorn IndustryEndnotes; Section II: Igniting Growth; 6. Applying "The 80-80 Rule"; 7. Setting Up for Success; Leadership Foresight and Courage to Invest; A New Breed of Leaders; Teaming the Right Talent; Reflections on the Experiment in Challenging the Status Quo; Endnote; 8. Finding White Spaces; Embrace the Need, Money Will Follow; Outside In First, Inside Out Next; Endnotes; 9. Developing New Ventures; Design for the End User, but Consider the Ecosystem; Keep It Modular; Keep It Simple; 10. Becoming Adept at Partnering

• 505

  ▼a  Partnerships That Span Development and CommercializationMaking Partnerships Work; 11. Afterword; Authors; Index

• 590

  ▼a  Master record variable field(s) change: 650

• 650

  ▼a  Pharmaceutical industry
  ▼x  Technological innovations.

• 650

  ▼a  Pharmaceutical biotechnology.

• 650

  ▼a  Biopharmaceutics.

• 650

  ▼a  Organizational change.

• 650

  ▼a  Biopharmaceutics.
  ▼2  fast
  ▼0  (OCoLC)fst00832650

• 650

  ▼a  Organizational change.
  ▼2  fast
  ▼0  (OCoLC)fst01047828

• 650

  ▼a  Pharmaceutical biotechnology.
  ▼2  fast
  ▼0  (OCoLC)fst01060106

• 650

  ▼a  Pharmaceutical industry
  ▼x  Technological innovations.
  ▼2  fast
  ▼0  (OCoLC)fst01060184

• 650

  ▼a  Drug Industry.
  ▼0  (DNLM)D004345

• 650

  ▼a  Organizational Innovation.
  ▼0  (DNLM)D009936

• 650

  ▼a  Inventions.
  ▼0  (DNLM)D062069

• 650

  ▼a  Biopharmaceutics.
  ▼0  (DNLM)D001702

• 650

  ▼a  BUSINESS & ECONOMICS / Industries / General
  ▼2  bisacsh

• 655

  ▼a  Electronic books.

• 655

  ▼a  Electronic books.

• 700

  ▼a  Huth, Jeff.

• 776

  ▼i  Print version:
  ▼a  Kansal, Ruchin
  ▼t  Redefining Innovation : Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry.
  ▼d  Milton : Productivity Press,c2018,
  ▼z  9781138581043

• 856

  ▼3  EBSCOhost
  ▼u  http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1776354

• 938

  ▼a  EBL - Ebook Library
  ▼b  EBLB
  ▼n  EBL5391276

• 938

  ▼a  YBP Library Services
  ▼b  YANK
  ▼n  15365555

• 938

  ▼a  YBP Library Services
  ▼b  YANK
  ▼n  15467737

• 938

  ▼a  EBSCOhost
  ▼b  EBSC
  ▼n  1776354

• 938

  ▼a  YBP Library Services
  ▼b  YANK
  ▼n  15364051

• 990

  ▼a  강리원

• 991

  ▼a  eBook

• 994

  ▼a  92
  ▼b  N$T